Oxford COVID-19 vaccine programme opens for clinical trial recruitment
The researchers at the University of Oxford have started screening healthy volunteers between the ages of 18 and 55 for their upcoming ChAdOx1 nCoV-19 vaccine trial in the Thames Valley Region. The vaccine is based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein is already in production but still won’t be ready for … Read more